beta-lactams has been researched along with Recrudescence in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 6 (27.27) | 29.6817 |
2010's | 9 (40.91) | 24.3611 |
2020's | 5 (22.73) | 2.80 |
Authors | Studies |
---|---|
Almirante, B; Bosch-Nicolau, P; Burgos, J; Marquez-Algaba, E; Pigrau, C; Serra-Pladevall, J; Viñado, B | 1 |
Augenstein, VA; Colavita, PD; Heniford, BT; Horton, JM; Maloney, SR; Prasad, T; Schlosser, KA | 1 |
Gandhi, TN; Malani, PN | 1 |
Cavaco, LM; Hammerum, AM; Hansen, F; Hasman, H; Roer, L | 1 |
Atalla, E; Mylonakis, E | 1 |
McCarthy, KL; Paterson, DL | 1 |
Aarnio, M; Grönroos, J; Hurme, S; Nordström, P; Paajanen, H; Rantanen, T; Rautio, T; Salminen, P; Sippola, S; Tuominen, R | 1 |
Aarnio, M; Grönroos, JM; Hurme, S; Jartti, A; Mecklin, JP; Nordström, P; Paajanen, H; Rantanen, T; Rautio, T; Salminen, P; Sand, J; Tuominen, R; Virtanen, J | 1 |
Ambretti, S; Bartoletti, M; Ferraro, G; Furii, F; Giannella, M; Lewis, RE; Pancaldi, L; Pascale, R; Tedeschi, S; Toschi, A; Viale, P | 1 |
Alberola, J; Artero, A; Cano, A; Eiros, JM; Nogueira, JM | 1 |
Matull, WR; Morgan, MY; O'Beirne, J; O'Neill, S; Smith, R; Wright, G; Zambreanu, L | 1 |
Bejon, P; Bowler, IC; Walker, TM | 1 |
Childs, S; Colgan, R; Gomolin, IH; Gould, M; Gupta, K; Hooton, TM | 1 |
Aihara, Y; Harada, T; Ito, S; Machida, H; Teranishi, J; Yokota, S | 1 |
Chang, CM; Chen, PL; Ko, NY; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Shih, HI; Wang, LR; Wu, CJ; Yan, JJ | 1 |
Bayraktar, B; Dalgic, N; Dincer, E; Pelit, S; Sancar, M | 1 |
Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O | 1 |
Berthel, M; Heitz, D; Jehl, F; Kaltenbach, G; Kiesmann, M; Kuntzmann, F; Martin-Hunyadi, C; Noblet-Dick, M; Vogel, T | 1 |
Falagas, ME; Karamanis, EM; Matthaiou, DK; Moraitis, LI | 1 |
Cahen, P; Coustère, C; de Blic, J; Delacourt, C; Gaillard, JL; Le Bourgeois, M; Lenoir, G; Scheinmann, P; Silly, C | 1 |
Pedersen, HB; Rosborg, J | 1 |
Aittoniemi, J; Joki-Erkkilä, VP; Puhakka, H; Vuento, R | 1 |
2 review(s) available for beta-lactams and Recrudescence
Article | Year |
---|---|
Urinary tract infections. Current approaches, future directions.
Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacterial Infections; beta-Lactams; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Pregnancy; Prevalence; Recurrence; Sex Factors; Urinary Tract Infections | 2000 |
Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; beta-Lactams; Fluoroquinolones; Humans; Odds Ratio; Osteomyelitis; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Superinfection; Treatment Outcome | 2008 |
3 trial(s) available for beta-lactams and Recrudescence
Article | Year |
---|---|
Economic evaluation of antibiotic therapy versus appendicectomy for the treatment of uncomplicated acute appendicitis from the APPAC randomized clinical trial.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Cost-Benefit Analysis; Ertapenem; Finland; Humans; Length of Stay; Levofloxacin; Metronidazole; Middle Aged; Recurrence; Sick Leave; Treatment Outcome; Young Adult | 2017 |
Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; beta-Lactams; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Levofloxacin; Male; Metronidazole; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Young Adult | 2018 |
Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Serum Bactericidal Test; Sputum; Treatment Outcome | 1995 |
17 other study(ies) available for beta-lactams and Recrudescence
Article | Year |
---|---|
Risk Factors for Relapse in Acute Bacterial Prostatitis: the Impact of Antibiotic Regimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; beta-Lactams; Chronic Disease; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Prostatitis; Pyelonephritis; Quinolones; Recurrence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
The association of penicillin allergy with outcomes after open ventral hernia repair.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Drug Hypersensitivity; Female; Fistula; Hernia, Ventral; Herniorrhaphy; Humans; Male; Middle Aged; Penicillins; Postoperative Complications; Prospective Studies; Recurrence; Reoperation; Risk Factors; Surgical Wound Infection; Treatment Outcome | 2020 |
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.
Topics: Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
Characterisation of extended-spectrum β-lactamase/plasmid AmpC-β-lactamase-producing Escherichia coli isolates from long-term recurrent bloodstream infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Recurrence; Sepsis; Virulence; Virulence Factors | 2020 |
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2020 |
Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Retrospective Studies; Risk Factors; Tertiary Care Centers; Young Adult | 2017 |
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactams; Enterobacteriaceae Infections; Female; Humans; Incidence; Italy; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Failure; Young Adult | 2019 |
Pyelonephritis in pregnancy. How adequate is empirical treatment?
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Comorbidity; Escherichia coli Infections; Female; Fosfomycin; Hospitals, University; Humans; Inappropriate Prescribing; Microbial Sensitivity Tests; Obstetrics and Gynecology Department, Hospital; Pregnancy; Pregnancy Complications, Infectious; Pyelonephritis; Recurrence; Retrospective Studies; Spain; Treatment Outcome; Young Adult | 2013 |
Recurrent bacteremia due to retained embolized glue following variceal obliteration.
Topics: Adult; Bacteremia; beta-Lactams; Embolism; Embolization, Therapeutic; Endoscopy, Gastrointestinal; Ertapenem; Escherichia coli Infections; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Recurrence; Risk Assessment; Severity of Illness Index; Tissue Adhesives; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Catheterization, Central Venous; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Female; Glycopeptides; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2009 |
Extended-spectrum beta-lactamase-producing bacteria and vesicoureteral reflux in children.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Infant; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Pyelonephritis; Recurrence; Urinary Tract Infections; Vesico-Ureteral Reflux | 2010 |
Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Diabetes Complications; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Osteomyelitis; Pyomyositis; Recurrence; Salvage Therapy; Tigecycline; Treatment Outcome | 2010 |
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Follow-Up Studies; Hospitals; Humans; Infant; Male; Pyelonephritis; Recurrence; Retrospective Studies; Turkey; Urinary Tract Infections | 2011 |
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors | 2012 |
[Urinary tract infections due to wide spectrum beta lactamase producing enterobacteriaceae].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Geriatrics; Hospital Departments; Humans; Length of Stay; Male; Recurrence; Survival Rate; Treatment Failure; Urinary Tract Infections | 2002 |
Necrotizing external otitis: aminoglycoside and beta-lactam antibiotic treatment combined with surgical treatment.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Debridement; Diabetes Complications; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Necrosis; Otitis Externa; Pseudomonas Infections; Recurrence; Retrospective Studies; Time Factors | 1997 |
beta-Lactamase-producing Moraxella catarrhalis may prevent the emergence of penicillin-resistant Streptococcus pneumoniae in children with recurrent acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Nasopharynx; Otitis Media; Penicillin Resistance; Recurrence; Streptococcus pneumoniae | 2002 |